InvestSMART

Invex Therapeutics Ltd (ASX: IXC) - Announcements

- Current share price for IXC : $0.105

ASX company news and announcements for Invex Therapeutics Ltd (IXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invex Therapeutics Ltd (IXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invex Therapeutics Ltd (IXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invex Therapeutics Ltd (IXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Exenatide Meets Key Endpoints in IIH Clinical Trial 20 May 2020 9:33AM $1.495 $0.105 fallen by 92.98%
$8 Trading Halt 18 May 2020 9:37AM $1.495 $0.105 fallen by 92.98%
$8 Virtual Health Conference Presentation 1 May 2020 2:30PM $1.170 $0.105 fallen by 91.03%
$8 Virtual Heath Conference 29 Apr 2020 9:32AM $1.075 $0.105 fallen by 90.23%
$8 Phase II Clinical Trial Update 23 Apr 2020 11:20AM $1.010 $0.105 fallen by 89.60%
$8 Appendix 3G - Issue of Options 14 Apr 2020 10:42AM $0.940 $0.105 fallen by 88.83%
$8 Quarterly Report and Appendix 4C 2 Apr 2020 10:15AM $0.785 $0.105 fallen by 86.62%
$8 Appendix 2A 30 Mar 2020 10:45AM $0.700 $0.105 fallen by 85%
$8 Investor Presentation 9 Mar 2020 8:18AM $1.120 $0.105 fallen by 90.63%
$8 Appendix 4D and Half-year Report 27 Feb 2020 10:16AM $1.050 $0.105 fallen by 90%
$8 Appendix 3B 28 Jan 2020 5:00PM $1.000 $0.105 fallen by 89.50%
$8 Appendix 3B 21 Jan 2020 11:19AM $1.130 $0.105 fallen by 90.71%
$8 Appendix 4C - quarterly 17 Jan 2020 10:00AM $0.985 $0.105 fallen by 89.34%
$8 Completion of Exenatide Phase II Clinical Trial 13 Jan 2020 8:17AM $0.940 $0.105 fallen by 88.83%
$8 Change of Director's Interest Notice x4 22 Nov 2019 3:45PM $0.730 $0.105 fallen by 85.62%
$8 Appendix 3B 22 Nov 2019 10:20AM $0.745 $0.105 fallen by 85.91%
$8 Results of Meeting 21 Nov 2019 10:58AM $0.805 $0.105 fallen by 86.96%
$8 Open Briefing Presentation 19 Nov 2019 11:48AM $0.765 $0.105 fallen by 86.27%
$8 Invitation to Open Briefing 28 Oct 2019 1:59PM $0.600 $0.105 fallen by 82.50%
$8 Appendix 4C - quarterly 17 Oct 2019 9:06AM $0.575 $0.105 fallen by 81.74%
$8 Phase II Recruitment Completed 15 Oct 2019 9:16AM $0.600 $0.105 fallen by 82.50%
$8 Japanese Patent Granted 7 Oct 2019 10:59AM $0.650 $0.105 fallen by 83.85%
$8 Notice of Annual General Meeting/Proxy Form 3 Oct 2019 10:29AM $0.650 $0.105 fallen by 83.85%
$8 Phase II Trial Update 11 Sep 2019 10:11AM $0.555 $0.105 fallen by 81.08%
$8 Appendix 4G 29 Aug 2019 8:04AM $0.630 $0.105 fallen by 83.33%

251 - 275 of 300 results

Page 11 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.